Strauss LG - Search Results

1

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels.

Yalcin AD, Cilli A, Bisgin A, Strauss LG, Herth F. Yalcin AD, et al. Among authors: strauss lg. Expert Opin Biol Ther. 2013 Sep;13(9):1335-41. doi: 10.1517/14712598.2013.819338. Epub 2013 Jul 24. Expert Opin Biol Ther. 2013. PMID: 23883435

2

Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up.

Yalcin AD, Uçar S, Gumuslu S, Strauss LG. Yalcin AD, et al. Among authors: strauss lg. Immunopharmacol Immunotoxicol. 2013 Aug;35(4):524-7. doi: 10.3109/08923973.2013.811598. Epub 2013 Jul 10. Immunopharmacol Immunotoxicol. 2013. PMID: 23841472 Clinical Trial.

3

A case of toxic epidermal necrolysis with diverse etiologies: successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels.

Yalcin AD, Karakas AA, Soykam G, Gorczynski RM, Sezer C, Bisgin A, Strauss LG. Yalcin AD, et al. Among authors: strauss lg. Clin Lab. 2013;59(5-6):681-5. doi: 10.7754/clin.lab.2012.120814. Clin Lab. 2013. PMID: 23865370

4

Omalizumab (anti-IgE) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 month follow-up.

Yalcin AD, Gorczynski RM, Cilli A, Strauss L. Yalcin AD, et al. Clin Lab. 2014;60(9):1561-4. doi: 10.7754/clin.lab.2013.130302. Clin Lab. 2014. PMID: 25291953

5

Celik B, Yalcin AD, Bisgin A, Dimitrakopoulou-Strauss A, Kargi A, Strauss LG. Celik B, et al. Among authors: strauss lg. Med Sci Monit. 2013 Oct 21;19:875-82. doi: 10.12659/MSM.889605. Med Sci Monit. 2013. PMID: 24145180 Free PMC article.

6

Correlation of serum proteomics patterns of sCD200 (OX-2), sApo-2L (sTRAIL), vitamin-D and homocysteine to quantitative FDG-PET/CT findings in newly diagnosed non-small cell lung cancer.

Bisgnin A, Yalcin AD, Gumuslu S, Kargi B, Kargi A, Savas B, Strauss LG. Bisgnin A, et al. Among authors: strauss lg. J BUON. 2013 Oct-Dec;18(4):1099-100. J BUON. 2013. PMID: 24344047 No abstract available.

7

Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET.

Dimitrakopoulou-Strauss A, Georgoulias V, Eisenhut M, Herth F, Koukouraki S, Mäcke HR, Haberkorn U, Strauss LG. Dimitrakopoulou-Strauss A, et al. Among authors: strauss lg. Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):823-30. doi: 10.1007/s00259-005-0063-5. Epub 2006 Mar 29. Eur J Nucl Med Mol Imaging. 2006. PMID: 16570185

8

The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions.

Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, Wu H, Burger C, Bernd L, Ewerbeck V. Dimitrakopoulou-Strauss A, et al. Among authors: strauss lg. J Nucl Med. 2002 Apr;43(4):510-8. J Nucl Med. 2002. PMID: 11937595 Free article.

9

PET imaging of prostate cancer with 11C-acetate.

Dimitrakopoulou-Strauss A, Strauss LG. Dimitrakopoulou-Strauss A, et al. Among authors: strauss lg. J Nucl Med. 2003 Apr;44(4):556-8. J Nucl Med. 2003. PMID: 12679399 Free article. Review. No abstract available.

10

Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics.

Strauss LG, Dimitrakopoulou-Strauss A, Haberkorn U. Strauss LG, et al. J Nucl Med. 2003 Dec;44(12):1933-9. J Nucl Med. 2003. PMID: 14660719 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters